SUBSCRIBE
SUBSCRIBE
News   Policy

AstraZeneca PLC Lung Cancer Pill May Get Second Chance After Tests

November 21, 2008 | 
1 min read
WASHINGTON, Nov 20 (Reuters) - The lung cancer pill Iressa has shown surprising results for patients with advanced disease where it has been at least as effective as a standard chemotherapy treatment, researchers reported on Thursday.
Regulatory
AstraZeneca Pharmaceuticals LP
MORE ON THIS TOPIC
Art collage, hands and scales of justice. The concept of the law of the judge.
Legal
Former Emergent CEO Hit With Insider Trading Lawsuit
January 16, 2026
 · 
2 min read
 · 
Tristan Manalac
Drug pricing
Trump Takes Drug Pricing Fight To Insurers With ‘The Great Healthcare Plan’
January 15, 2026
 · 
2 min read
 · 
Annalee Armstrong
Trendy halftone collage. A hand holds a ringing alarm clock. Time, hurry up. Vector business concepts for graphic and web design, marketing and print materials, social media. Vector illustration
FDA
FDA Delays Decision for Lilly’s Obesity Pill Orforglipron, Other Priority Voucher Awardees: Report
January 15, 2026
 · 
2 min read
 · 
Tristan Manalac
Buying tickets. The hands of the person holding the tickets. Isolated illustration on a yellow background. Template for the design. Trending vector graphics.
Business
Jazz Sells Priority Review Voucher for $200M as Program’s Renewal Languishes in Senate
January 15, 2026
 · 
2 min read
 · 
Tristan Manalac